drugset / Trial / NCT05703464

Elobixibat for Chronic Constipation Without Defecation Desire

NCT05703464

Phase 4 Terminated 40 enrolled International University of Health and Welfare
NaSingle-groupOpen-labelTreatment

Summary

Patients of chronic constipation without defecation desire will be orally administered elobixibat 10 mg once daily before meals for 4 weeks. The primary endpoint of the pre/post comparative study will be the percentage of improvement in bowel movements from Week 2 of the observation period at Week 4 of the treatment period.

Timeline

Start
2023-02-09
Primary completion
2023-03-03
Completion
2023-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Elobixibat Small molecule 10 mg Oral

Indications